Wai Yuen Tong Infantile Calming Herbal Granules
Wai Yuen Tong Infantile Calming Herbal Granules, NPN 80050460: natural health product licensed in Canada. Medicinal ingredients: Coix lacryma-jobi var. ma-yuen, Crataegus pinnatifida, Cryptotympana pustulata, Glycyrrhiza uralensis.
If this product were sold in France
- Legal conditions
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Coix lacryma-jobi var. ma-yuen Source : Graine(s) Extraction ratio : 4.26:1 Dry plant equivalent : 3,125 mg | 734 mg | Not calculated |
| Crataegus pinnatifida Source : Fruit Extraction ratio : 4.26:1 Dry plant equivalent : 1,562 mg | 366 mg | Not calculated |
| Cryptotympana pustulata Source : Dépouille larvale Extraction ratio : 4.26:1 Dry plant equivalent : 390 mg | 92 mg | Not calculated |
| Glycyrrhiza uralensis Source : Racine et rhizome Extraction ratio : 4.26:1 Dry plant equivalent : 390 mg | 92 mg | Not calculated |
| Lophatherum gracile Source : Feuille Extraction ratio : 4.26:1 Dry plant equivalent : 2,344 mg | 550 mg | Not calculated |
| Oryza sativa Source : Graine(s) Extraction ratio : 4.26:1 Dry plant equivalent : 3,125 mg | 734 mg | Not calculated |
| Uncaria rhynchophylla Source : Branche(s) Extraction ratio : 4.26:1 Dry plant equivalent : 1,172 mg | 275 mg | Not calculated |
Non-medicinal ingredients
Sucrose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years ; maximum: 18 years | minimum: 1 sachet ; maximum: 2 sachet | 3 Tous les jours |
Uses authorised in Canada
Used in Traditional Chinese Medicine to boost the appetite and remove food stagnation, clear heat and settle fright. Calm nerves, clear away heat evil and improve appetite. Suitable for children with problems of internal heat, poor sleep quality, arousal, wakefulness and poor appetite.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
If you are taking prescription medications, stimulant laxatives and diuretics, consult a health care practitioner prior to use. If symptoms persist or worsen, or if new symptoms develop, consult a health care practitioner. If you have serious or major conditions, any type of acute infection or hypokalemia, consult a health care practitioner prior to use. May cause drowsiness. Exercise caution when driving or operating machinery. Please use caution when recommending, as this product contains the following ingredients which may not be suited to patients with certain deficiencies or excesses: Coix lacryma-jobi var, mayuen, cryptotympana pustulata, Uncaria rhynchophylla.
Product record
- Licence holder
- Wai Yuen Tong Medicine Co. Ltd.
- NPN or DIN-HM
- 80050460
- Status
- Active licence
- Licence date
- 29 April 2014
- Revision date
- 2 May 2019
- Form
- Granules
- Route of administration
- Orale
- Application type
- Traditionnelle
Source
Official Health Canada record, licence 80050460
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Glycyrrhiza uralensis
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
Sources cited by Health Canada (1)
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
Sources cited by Health Canada (2)
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
- Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (4)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
Sources cited by Health Canada (4)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Wai Yuen Tong Infantile Calming Herbal Granules (Wai Yuen Tong Medicine Co. Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80050460-wai-yuen-tong-infantile-calming-herbal-granules, updated 2 May 2019.